28 State AGs Ask FDA to Reconsider Approval of Zohydro ER Because of Abuse Potential (FREE)
By Kelly Young Twenty-eight state attorneys general have asked the FDA to reconsider its approval of Zohydro ER, a hydrocodone-only painkiller, or consider an expedited schedule for developing an abuse-deterrent version. In … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 16, 2013 Category: Primary Care Source Type: news

Mallinckrodt reports positive efficacy results from Phase III study of pain drug
Mallinckrodt has released positive efficacy results from the Phase III clinical trial of MNK-155, an investigational extended-release oral formulation of hydrocodone and acetaminophen evaluated for the management of moderate to moderately severe acut… (Source: Drug Development Technology)
Source: Drug Development Technology - December 13, 2013 Category: Pharmaceuticals Source Type: news

Killing Pain: AGs Want FDA to Review Zohydro Approval
(MedPage Today) -- Attorneys general from 28 states have asked the U.S. Food and Drug Administration to reconsider its approval of the powerful narcotic painkiller known as Zohydro (hydrocodone bitartrate). (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - December 12, 2013 Category: Psychiatry Source Type: news

hydrocodone/acetaminophen, Vicodin, Vicodin ES, Vicodin HP, Anexsia, Lortab, Lorcet, Lorcet Plus, No
Title: hydrocodone/acetaminophen, Vicodin, Vicodin ES, Vicodin HP, Anexsia, Lortab, Lorcet, Lorcet Plus, NoCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/11/2013 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - December 11, 2013 Category: Anesthesiology Source Type: news

hydrocodone/acetaminophen, Vicodin, Vicodin ES, Vicodin HP, Anexsia, Lortab, Lorcet, Lorcet Plus, No
Title: hydrocodone/acetaminophen, Vicodin, Vicodin ES, Vicodin HP, Anexsia, Lortab, Lorcet, Lorcet Plus, NoCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/11/2013 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 11, 2013 Category: Drugs & Pharmacology Source Type: news

FDA recommends schedule II for hydrocodone combinations
Read the full story on MD Consult: FDA recommends schedule II for hydrocodone combinations (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - December 10, 2013 Category: Journals (General) Source Type: news

OxyContin Tops List of Abused Prescription Drugs: Survey
Painkillers like Vicodin also popular, researchers found (Source: WebMD Health)
Source: WebMD Health - December 9, 2013 Category: Consumer Health News Source Type: news

OxyContin Tops List of Abused Prescription Drugs
Painkillers like Vicodin also popular, researchers found Source: HealthDay Related MedlinePlus Page: Prescription Drug Abuse (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 9, 2013 Category: Consumer Health News Source Type: news

A Forever Recovery Launches Vicodin Information Center to Raise...
A Forever Recovery, a leading addiction treatment center that has pioneered a moral reasoning approach to recovery that empowers each individual client to access the spiritual, cognitive, and...(PRWeb December 06, 2013)Read the full story at http://www.prweb.com/releases/A-Forever-Recovery/Vicodin/prweb11397669.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 7, 2013 Category: Pharmaceuticals Source Type: news

Factors that influence the choice of abused pain drugs
Prescription opioid abuse has reached epidemic levels in the past 15 years. Scientists investigating why people favor one drug over another have found that oxycodone and hydrocodone are the drugs of choice for 75% of opioid-dependent individuals. Their results, published in the current issue of PAIN®, show that oxycodone was the most popular drug overall because of the quality of the high for those who sought such effects. Nonetheless, hydrocodone remains one of the most popular primary drugs, even though it has lower euphoric qualities. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

Addiction and Dependency of Vicodin Covered in New A Forever Recovery...
A Forever Recovery, a leading addiction treatment center that has pioneered a moral reasoning approach to recovery that empowers each individual client to access the spiritual, cognitive, and...(PRWeb December 03, 2013)Read the full story at http://www.prweb.com/releases/A-Forever-Recovery/Vicodin/prweb11378257.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 3, 2013 Category: Pharmaceuticals Source Type: news

Prescription opioid abusers prefer to get high on oxycodone and hydrocodone
(Elsevier Health Sciences) Prescription opioid abuse has reached epidemic levels in the past 15 years. Scientists investigating why people favor one drug over another have found that oxycodone and hydrocodone are the drugs of choice for 75 percent of opioid-dependent individuals. Their results show that oxycodone was the most popular drug overall because of the quality of the high. Nonetheless, hydrocodone remains one of the most popular primary drugs, even though it has lower euphoric qualities. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 2, 2013 Category: Global & Universal Source Type: news

The FDA and Hydrocodone
Hydrocodone-acetaminophen combinations are moved to Schedule II from Schedule III while single-agent extended release hydrodocone is approved without a tamper-resistant mechanism. Here, pain specialist Dr Steven King opines on both FDA decisions. (Source: Consultant Live)
Source: Consultant Live - November 13, 2013 Category: Primary Care Source Type: news

Commentary – Hydrocodone rescheduling: Intended and unintended consequences
Read the full story on MD Consult: Commentary – Hydrocodone rescheduling: Intended and unintended consequences (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - November 13, 2013 Category: Journals (General) Source Type: news

Why the FDA Is Wrong on Vicodin
The FDA's recent decision on hydrocodone-containing drugs such as Vicodin is flawed in many ways. It may not curb abuse, but it almost certainly will harm pain patients.read more (Source: Psychology Today Addiction Center)
Source: Psychology Today Addiction Center - November 8, 2013 Category: Addiction Authors: Judy Foreman Tags: Addiction Health chronic pain Source Type: news

Zohydro ER (Hydrocodone bitartrate Extended Release Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2013 Category: Drugs & Pharmacology Source Type: news

FDA Approves Hydrocodone-Only Drug
(Source: About.com Alcoholism)
Source: About.com Alcoholism - November 5, 2013 Category: Addiction Source Type: news

Must-Read: FDA approves long-acting hydrocodone despite warning from its own advisory panel (Weekly Web Review in Toxicology)
This study design allows researchers to enroll only subjects who have already been shown to tolerate and respond to the drug. Critics of this method argue that it stacks the deck in favor of good results, and in no way simulates real-world conditions or predicts after-market experience. Last December, an FDA panel voted against approving the drug. One panel member, medical toxicologist Jeanmarie Perrone, said she was “surprised” when the drug was approved. In a related story, the Journal Sentinal previously reported that the enhanced enrollment design was worked out at annual private meetings between drug ...
Source: The Poison Review - November 3, 2013 Category: Toxicology Authors: Leon Tags: Medical battery ingestion central park ecstasy FDA federal drug administration hydrocodone mdma pma toxic plant zohydroer Source Type: news

Avoiding addiction when powerful opioid painkillers are needed
Sometimes the best way to ease pain is with the type of prescription painkiller known as an opioid. Despite their "addictive" reputation in the media, the majority of people use opioids safely and without addition, reports the November 2013 Harvard Health Letter. Opioids are a class of painkillers with high addictive potential. They include oxycodone (OxyContin), hydrocodone (Vicodin), hydromorphone (Dilaudid), and meperidine (Demerol). Opioids are typically used for the short term, such as for treating severe pain following surgery. They are also sometimes used long-term for relieving pain related to cancer or a...
Source: New Harvard Health Information - November 3, 2013 Category: Consumer Health News Source Type: news

With Rise of Painkiller Abuse, a Closer Look At Heroin
Abuse of prescription painkillers is a "growing, deadly epidemic," according to the Centers for Disease Control and Prevention. On Oct. 24, the Food and Drug Administration recommended putting new restrictions on hydrocodone, sold as Vicodin and other brand names. (Source: RWJF News Digest - Public Health)
Source: RWJF News Digest - Public Health - November 2, 2013 Category: American Health Source Type: news

FDA Wants Hydrocodone Combo Pain Meds ReclassifiedFDA Wants Hydrocodone Combo Pain Meds Reclassified
The agency says it will recommend changing hydrocodone combination products to Schedule II controlled substances. Still, the FDA just approved a single-entity hydrocodone and some find the timing 'odd.' Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

FDA Hydrocodone Restrictions Lead to Illegal Drug Use? Rapid Detox the...
With the FDA set to reclassify hydrocodone pills as a Schedule II drug, Waismann Method rapid detox is glad to see the addictive drug correctly classed. However, they also worry about the increased...(PRWeb October 30, 2013)Read the full story at http://www.prweb.com/releases/2013/10/prweb11275619.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 1, 2013 Category: Pharmaceuticals Source Type: news

FDA approves extended-release, single-entity hydrocodone product
Zohydro ER, a Schedule II controlled substance under the Controlled Substances Act, is the first FDA-approved single-entity (not combined with an analgesic such as acetaminophen) and extended-release hydrocodone product. Zohydro ER will offer prescribers an additional therapeutic option to treat pain, which is important because individual patients may respond differently to different opioids. Zohydro ER is in the class of extended-release/long-acting (ER/LA) opioid analgesics... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

FDA OKs New Hydrocodone Painkiller
Title: FDA OKs New Hydrocodone PainkillerCategory: Health NewsCreated: 10/25/2013 4:36:00 PMLast Editorial Review: 10/28/2013 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - October 28, 2013 Category: Anesthesiology Source Type: news

Extended-Release Single-Entity Hydrocodone Product
FDA Approves Extended-Release, Single-Entity Hydrocodone Product (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 28, 2013 Category: Journals (General) Source Type: news

FDA recommends schedule II for hydrocodone combinations
Read the full story on MD Consult: FDA recommends schedule II for hydrocodone combinations (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - October 28, 2013 Category: Journals (General) Source Type: news

Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - October 27, 2013 Category: Pharmaceuticals Source Type: news

Zogenix Painkiller Gets FDA Approval Despite Criticism
The Food and Drug Administration on Friday approved an extended-release version of the narcotic painkiller hydrocodone despite a recommendation by its advisory committee that the drug should be rejected because of its potential for abuse. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 26, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA approves single-entity hydrocodone painkiller Zohydro
WASHINGTON, Oct. 25 (UPI) -- U.S. Food and Drug Administration said Friday if approved Zohydro ER -- hydrocodone bitartrate extended-release capsules -- for the management of pain. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 25, 2013 Category: Consumer Health News Source Type: news

FDA to restrict prescription painkillers such as Vicodin.
WASHINGTON, Oct. 25 (UPI) -- A U.S. Food and Drug Administration official says the agency wants the government to approve restrictions on prescription painkillers such as Vicodin. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 25, 2013 Category: Consumer Health News Source Type: news

FDA OKs Zohydro, 1st Opioid-Only Painkiller
WASHINGTON (MedPage Today) -- The FDA has approved Zohydro ER (hydrocodone bitartrate extended release tablets) for long-term treatment of refractory severe pain. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 25, 2013 Category: Psychiatry Source Type: news

FDA OKs Zohydro, 1st Hydrocodone-Only Painkiller
WASHINGTON (MedPage Today) -- The FDA has approved Zohydro ER (hydrocodone bitartrate extended release tablets) for long-term treatment of refractory severe pain. (Source: MedPage Today Pain Management)
Source: MedPage Today Pain Management - October 25, 2013 Category: Anesthesiology Source Type: news

FDA Okays First Single-Entity Extended-Release HydrocodoneFDA Okays First Single-Entity Extended-Release Hydrocodone
The FDA has approved a single-entity extended-release formulation of hydrocodone for long-term treatment of chronic pain for which alternatives are not adequate. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Pure hydrocodone, stronger than Vicodin, approved by FDA
Zohydro ER's approval comes as surprise since agency's advisory panel gave overwhelmingly negative review of product last year (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 25, 2013 Category: Consumer Health News Source Type: news

FDA approves extended-release, single-entity hydrocodone product
The U.S. Food and Drug Administration today approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, long-term treatment and for which alternative treatment options are inadequate. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 25, 2013 Category: American Health Source Type: news

FDA Urges Tighter Controls on Certain Prescription Painkillers
Large supplies of often-abused drugs such as Vicodin should be harder to obtain, agency says (Source: WebMD Health)
Source: WebMD Health - October 25, 2013 Category: Consumer Health News Source Type: news

FDA aims to tighten control of hydrocodone
One person dies every 19 minutes from a prescription drug overdose in the United States. (Source: WDSU.com - Health)
Source: WDSU.com - Health - October 25, 2013 Category: Consumer Health News Source Type: news

FDA Recommends Restrictions on Prescribed Painkillers
The agency says that hydrocodone-containing drugs should be subject to the same restrictions as other narcotic drugs (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2013 Category: Pharmaceuticals Source Type: news

FDA recommends tightening access to hydrocodone pain-killers
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin. (Source: Reuters: Health)
Source: Reuters: Health - October 25, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

F.D.A. Urging a Tighter Rein on Painkillers
The Food and Drug Administration recommended new restrictions on prescriptions for drugs like Vicodin, which combine the narcotic hydrocodone with over-the-counter pain medication.     (Source: NYT Health)
Source: NYT Health - October 25, 2013 Category: Consumer Health News Authors: By BARRY MEIER Tags: Regulation and Deregulation of Industry Pain-Relieving Drugs Drugs (Pharmaceuticals) Drug Abuse and Traffic Food and Drug Administration Woodcock, Janet Source Type: news

Video: FDA recommends tighter controls on common painkillers
The proposed change reclassifies hydrocodone products, such as Vicodin, and categorizes them in the most restrictive way, like painkillers such as morphine. Dr. Jon LaPook reports on what the new classification means. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 25, 2013 Category: Consumer Health News Source Type: news

FDA ruling on Vicodin—Burdens for Pain Patients
The FDA is severely restricting access to Vicodin and other hydrocodone-containing products.read more (Source: Psychology Today Addiction Center)
Source: Psychology Today Addiction Center - October 25, 2013 Category: Addiction Authors: Judy Foreman Tags: Addiction Health FDA pain patients vicodin Source Type: news

FDA Urges New Limits on Pain Drugs
The FDA recommended imposing more severe restrictions on the prescribing of Vicodin and other commonly used narcotic painkilling drugs in an effort to combat their widespread abuse. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 25, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Urges Tighter Controls on Certain Prescription Painkillers
Large supplies of often-abused drugs such as Vicodin should be harder to obtain, agency says Source: HealthDay Related MedlinePlus Pages: Pain Relievers, Prescription Drug Abuse (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 25, 2013 Category: Consumer Health News Source Type: news

FDA Plans to Restrict Vicodin Rx
(MedPage Today) -- The FDA wants to tighten the reins on hydrocodone combination drugs such as Vicodin, recommending that they be classified as Schedule II narcotics like OxyContin and fentanyl. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 25, 2013 Category: Psychiatry Source Type: news

FDA recommends reclassifying Vicodin as harder drug
FDA wants to reclassify pills like Vicodin into same drug category as OxyContin, making it more difficult to obtain (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 24, 2013 Category: Consumer Health News Source Type: news

FDA recommends tightening access to hydrocodone pain-killers
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin. (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

F.D.A. Seeks Tighter Control on Prescriptions for Class of Painkillers
The Food and Drug Administration recommended new restrictions on prescriptions for drugs like Vicodin, which combine the narcotic hydrocodone with over-the-counter pain medication.     (Source: NYT Health)
Source: NYT Health - October 24, 2013 Category: Consumer Health News Authors: By BARRY MEIER Tags: Regulation and Deregulation of Industry Pain-Relieving Drugs Drugs (Pharmaceuticals) Drug Abuse and Traffic Food and Drug Administration Woodcock, Janet Source Type: news

Study looks at how patients and their doctors discuss risks involved in taking opioids for chronic pain
Although the popular press -- from entertainment news to the crime blotter -- has paid significant attention to the dangers of hydrocodone, oxycodone and other opioids, little is known about whether and how this issue comes up in discussions between chronic pain patients and their physicians. A pilot study by researchers from the Roudebush VA Medical Center and the Regenstrief Institute is believed to be the first to analyze the nature of these conversations in regular primary care appointments... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 24, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

Clinical trial evaluates outpatient detoxification in prescription opioid abusers
Patients addicted to prescription opioids (POs) who are taking buprenorphine (a medication used in opioid addiction treatment) may respond better to tapering of the drug over four weeks than over shorter periods when the taper is followed by naltrexone (a medication that blocks opioid strength), according to a clinical trial report by Stacey C. Sigmon, Ph.D., of the University of Vermont, Burlington, and colleagues. Abuse of prescription opioid drugs, such as oxycodone, hydrocodone and hydromorphone, are a public health problem, according to the study background... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 23, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news